By identifying and supporting emerging medical technologies, Maximum Life Foundation will help reverse the human aging process by 2033 – leading to your open-ended youthful lifespan. Using 7 simple steps, we also show you how to stay alive and healthy until we reach our goal. The world mourns 100,000 “premature” deaths every day to aging. We also lose their wisdom, knowledge and skills. MaxLife plans to save thousands of those precious lives… every day.
David Kekich is President/CEO of Maximum Life Foundation that focuses on aging research. In 1999, he realized the inevitability that science will someday control the human aging process. He understood human beings will someday be able to enjoy very long health spans by studying aging research, the root cause of most deadly diseases.
The problem? He was in a race against the clock. He was faced with the possibility of being part of the “last generation to suffer from heart disease, cancer, Alzheimer’s and other aging related diseases”. His solution was to further that aging research and hopefully move it forward by establishing the Maximum Life Foundation.
Mr. Kekich holds a B.S. from Penn State in Business Management. He founded the country’s largest life insurance master general agency, co-founded the world’s biggest private stock loan company, sold and developed real estate and arranged venture capital funding for 16 private companies. He is a recognized expert on private investing and authored the venture capital handbook “How The Rich Get Richer With Quiet Private Investments”.
Mr. Kekich founded three public and five private companies, was engaged as a consultant to 41 private and six public companies and served as director to four public and seven private corporations. In 1999, he started the “Maximum Life Foundation”, a 501(c)(3) corporation dedicated to curing aging related diseases. He networked throughout the anti-aging segment of the biotech industry and developed a business model to put life sciences aging research on the fast track. Now he specializes in raising funding and providing management for life sciences related technologies.